Mercado fechado

Sinopharm Group Co., Ltd. (1099.HK)

HKSE - HKSE Preço Adiado. Moeda em HKD.
Adicionar à lista
18,620+0,280 (+1,53%)
No fechamento: 04:08PM HKT

Sinopharm Group Co., Ltd.

Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China
86 21 2305 2666
https://www.sinopharmgroup.com.cn

Setor(es)Healthcare
IndústriaMedical Distribution
Funcionários Integrais108.316

Principais Executivos

NomeTítuloPagarExercidoNascido em
Mr. Qingming YuExec. Chairman1,07MN/A1964
Mr. Yong LiuPres & Exec. Director1,04MN/A1969
Mr. Xiuchang JiangCFO & VPN/AN/A1964
Ms. Xiaojuan LiChief Financial OfficerN/AN/A1976
Mr. Yijian WuCompany Sec.N/AN/A1970
Mr. Wanyong LianVPN/AN/A1971
Mr. Shuangjun XuNon-Exec. VPN/AN/A1969
Mr. Maisong CaiVPN/AN/A1970
Os valores são a partir de 31 de dezembro de 2020, e os valores de compensação são relativos ao ano fiscal terminando naquela data. O pagamento é salário, bônus, etc. Exercido é o valor de opções exercidas durante o ano fiscal. Moeda em HKD.

Descrição

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2020, this segment had 8,977 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China.

Governança Corporativa

O QualityScore de governança da ISS da Sinopharm Group Co., Ltd. a partir de 26 de setembro de 2021 é 10. As principais pontuações para Auditoria são: 2; Conselho: 10; Direitos de Acionistas: 10; Compensação: 9.

Pontuações em governança corporativa são cortesia da Institutional Shareholder Services (ISS). As pontuações indicam a posição do decil em relação ao índice ou à região. Uma decil com pontuação 1 indica menor risco de governança, enquanto uma pontuação 10 indica um maior risco de governança.